Security key
15117F807
Cellectar Biosciences, Inc. - Common stock, par value $0.00001 (CLRB)
CUSIP: 15117F807
Q4 2024 13F Holders as of 31 Dec 2024
- Security type / class
- Equity / Common stock, par value $0.00001
- Total 13F shares
- 5,096,844
- Total 13F value
- $1,524,202
- Share change
- -8,895,325
- Put/Call ratio
- 28%
- SEC-reported price per share
- $0.30
- Number of holders
- 30
- Value change
- -$20,663,936
- Number of buys
- 15
- Number of sells
- 15
- Shares outstanding
- 43,754,363
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2024
Institutions
30
Top holders
10
CLRB full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Cellectar Biosciences, Inc. SEC filings
Cellectar Biosciences, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 15117F807
Recent filing periods:
Ownership snapshot
Top reported holders of CLRB - Cellectar Biosciences, Inc. - Common stock, par value $0.00001 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Laurence W. Lytton
Disclosed value leader
Rosalind Advisors, Inc.
Comparable rows
15/15
Latest evidence
31 Dec 2024
13D/G
13F
Lead comparable stake: 8.8%
13D/G row: Laurence W. Lytton
Showing 1-6 of 15 holder rows.
Quick read
Laurence W. Lytton leads the comparable SEC ownership view at 8.8%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Laurence W. Lytton's linked filing trail.
Comparable ownership
Top 5
Laurence W. Lytton
8.8%
Nantahala Capital Management, LLC
5.7%
Orin Hirschman
4.9%
Rosalind Advisors, Inc.
8.4%
AIGH Capital Management LLC
7.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Laurence W. Lytton |
13D/G
LYTTON LAURENCE W
|
8.8%
|
$1,147,086
3,955,470 shares
|
$0 | 31 Dec 2024 |
| Nantahala Capital Management, LLC |
13F
13D/G
Company
|
5.7%
from 13D/G
|
$5,804,629
2,712,443 shares
|
— | 30 Sep 2024 |
| Orin Hirschman |
13D/G
|
4.9%
|
$586,444
2,022,221 shares
|
$0 | 31 Dec 2024 |
| Rosalind Advisors, Inc. |
13F
Company
|
8.4%
|
$7,857,117
3,671,550 shares
|
— | 30 Sep 2024 |
| AIGH Capital Management LLC |
13F
Company
|
7.3%
|
$6,842,424
3,197,394 shares
|
— | 30 Sep 2024 |
| VANGUARD GROUP INC |
13F
Company
|
3.9%
|
$3,695,750
1,726,986 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
30
Shares
5,096,844
Rows available
30
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q3 2025 Across Filers
Q3 2025 holders
1
Q4 2024 holders
30
Holder diff
29
| Investor | Q3 2025 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend